Vantage Consulting Group Inc
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 12, 2025), Vantage Consulting Group Inc reported 3 stock positions worth $5.7 million. Its top holding was Babcock & Wilcox Enterpr (BW) at 40.5% of the portfolio, followed by Adc Therapeutics (ADCT, 31.9%) and Cibus (CBUS, 27.5%). Compared with Q1 2025, it sold out of 1 and reduced 1. The biggest sale was an exit from Fibrogen.
- Most Recent 13F
- Q4 2025
- Location
- VIRGINIA BEACH, VA
- CIK
- 0001843547
- Portfolio Value
- $5.7M (Q2 2025)
- SEC Filing
- 0001843547-25-000009 ↗ filed Aug 12, 2025
Holdings Value
Holdings 3 stocks · $5.7M
Portfolio Sells Q1 2025 → Q2 2025
| FIBROGEN INC | Sold out | 0.00% | −1.21 |
| ADCT Adc Therapeutics SA | Reduce -19.7% | 31.92% | +8.05 |
Portfolio Buys Q1 2025 → Q2 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q4 2025 | 3 | $19.7M | BW, ADCT, CBUS |
| Q3 2025 | 3 | $11.2M | BW, ADCT, CBUS |
| Q2 2025 | 3 | $5.7M | BW, ADCT, CBUS |
| Q1 2025 | 4 | $5.0M | CBUS, BW, ADCT, FIBROGEN INC |
| Q4 2024 | 5 | $10.5M | BW, CBUS, ADCT, PBPB, FIBROGEN INC |
| Q3 2024 | 4 | $11.4M | BW, CBUS, ADCT, FIBROGEN INC |
| Q2 2024 | 191 | $134.6M | SYNTAX STRATIFIED LARGE CAP, CBUS, SMDY, BW, SSLY |
| Q1 2024 | 212 | $157.3M | SYNTAX STRATIFIED LARGE CAP, CBUS, SMDY, ADCT, SSLY |